Cargando…

Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study

BACKGROUND: Long acting injectable (LAI) antipsychotics have been claimed to ensure treatment adherence and possibly reduce the daily burden of oral formulations. So far, only surveys investigating the theoretical prescribing attitudes of clinicians have been employed. On this basis, we aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbui, Corrado, Bertolini, Federico, Bartoli, Francesco, Calandra, Carmela, Callegari, Camilla, Carrà, Giuseppe, D’Agostino, Armando, Lucii, Claudio, Martinotti, Giovanni, Mastromo, Daniele, Moretti, Daniele, Monzani, Emiliano, Porcellana, Matteo, Prestia, Davide, Ostuzzi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768845/ https://www.ncbi.nlm.nih.gov/pubmed/33489087 http://dx.doi.org/10.1177/2045125320978102

Ejemplares similares

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study
por: D’Agostino, Armando, et al.
Publicado: (2022)

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
por: Barbui, Corrado, et al.
Publicado: (2016)

The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
por: Aguglia, Andrea, et al.
Publicado: (2021)

Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study
por: Bertolini, Federico, et al.
Publicado: (2021)

Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
por: Ostuzzi, Giovanni, et al.
Publicado: (2018)

Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
por: Meid, Andreas D., et al.
Publicado: (2017)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Physical health monitoring in antipsychotic depot clinic
por: Davies, Rebecca, et al.
Publicado: (2021)

Metabolic Syndrome Monitoring in Patients on Depot Antipsychotics
por: Ateem, Salah
Publicado: (2023)

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
por: Riboldi, Ilaria, et al.
Publicado: (2022)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
por: Bartoli, Francesco, et al.
Publicado: (2023)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Treatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication
por: POPP, BIANCA-STEPHANIE, et al.
Publicado: (2014)

Re-Audit of Prescribing Responsibility for Antipsychotic Depots for Shared Care Patients(PRAD-SCP)
por: Ziriki, Ayebakari, et al.
Publicado: (2023)

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
por: Turrini, Giulia, et al.
Publicado: (2017)

Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India
por: Raghavan, Vijaya, et al.
Publicado: (2020)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
por: Peng, Xiaomei, et al.
Publicado: (2011)

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients
por: Ascher-Svanum, Haya, et al.
Publicado: (2009)

Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team
por: Waterman, Harry, et al.
Publicado: (2023)

Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study
por: Ahmadkhaniha, Hamid-Reza, et al.
Publicado: (2014)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
por: Gastaldon, Chiara, et al.
Publicado: (2022)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
por: Potempa, Christoph, et al.
Publicado: (2018)

Improving Cardiac Monitoring for Patients on Depot Antipsychotic Medication in a Mental Health Service for Homeless People
por: Hall, Hugh, et al.
Publicado: (2023)

Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio
por: Moretti, Davide V., et al.
Publicado: (2013)

Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance
por: Ostuzzi, Giovanni, et al.
Publicado: (2017)

Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada
por: Lammers, Laura, et al.
Publicado: (2013)

Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial
por: Priebe, Stefan, et al.
Publicado: (2016)

Physical health monitoring of patients prescribed depot antipsychotic medication in north west Edinburgh community mental health team
por: Murdie, Douglas, et al.
Publicado: (2021)

Dental Depot
Publicado: (1862)

Dental Depot
Publicado: (1861)

Cannot write session to /tmp/vufind_sessions/sess_bp2qmifcqftnesniej19kr2ba3